Authors
Loading...
Study reveals machine learning combined with proteomics improves cardiovascular disease prediction in patients with type 2 diabetes mellitus, suggesting a personalized approach.
Yu et al. (2025) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: